文献速递头颈部肿瘤放疗

鼻咽癌患者选择性上颈照射与全颈照射未受累颈部的疗效与毒性:一项Meta分析

Efficacy and toxicities of elective upper-neck irradiation versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: A meta-analysis.
PubMed 文献 · Radiother Oncol · 2023-08-23

这项Meta分析纳入8项研究共2568例单侧或双侧颈部淋巴结阴性鼻咽癌患者,比较上颈照射(UNI)与全颈照射(WNI)的生存与毒性。UNI组区域无复发生存、局部无复发生存、无远处转移生存、无进展生存和总生存与WNI组相似,且1-2级甲状腺功能减退和1-2级吞咽困难发生率更低。作者认为对N0、N1甚至单侧N3病变,豁免下颈照射是可选方案。

要点

  • UNI与WNI的总生存、无进展生存及区域/局部/远处控制均无显著差异。
  • UNI组1-2级甲状腺功能减退(RR 0.75)和1-2级吞咽困难(RR 0.58)发生率低于WNI组。
  • 按N0、N1(仅咽后淋巴结转移)和单侧颈部淋巴结转移分层,区域无复发生存HR均未达统计学显著。

核心结论

  • 对单侧或双侧颈部淋巴结阴性鼻咽癌患者,UNI与WNI疗效相似且毒性更少。
  • 作者认为豁免未受累下颈照射对N0、N1甚至单侧N3病变是可选方案。

研究设计与样本

  • 系统检索截至2022年8月的主要数据库,纳入比较UNI与WNI生存和毒性的研究。
  • 共纳入8项研究、2568例患者,用R 4.0.5合并HR和RR,并按淋巴结状态、放疗技术和研究类型做亚组分析。

主要发现

  • UNI组与WNI组区域无复发生存HR 0.99(95%CI 0.57-1.74,P=0.975)、局部无复发生存HR 0.86(95%CI 0.53-1.41,P=0.559)、无远处转移生存HR 0.90(95%CI 0.63-1.29,P=0.581)、无进展生存HR 1.10(95%CI 0.73-1.67,P=0.642)、总生存HR 1.03(95%CI 0.77-1.37,P=0.866)。
  • N0亚组区域无复发生存HR 0.46(95%CI 0.04-5.16,P=0.529),N1仅咽后淋巴结转移亚组HR 1.12(95%CI 0.29-4.38,P=0.872),单侧颈部淋巴结转移亚组HR 1.02(95%CI 0.48-2.16,P=0.968),均未达统计学显著。
  • UNI组1-2级甲状腺功能减退发生率低于WNI组(RR 0.75,95%CI 0.57-0.97,P=0.031)。
  • UNI组1-2级吞咽困难发生率低于WNI组(RR 0.58,95%CI 0.42-0.80,P<0.001)。

临床怎么用

  • 作者认为对单侧或双侧颈部淋巴结阴性鼻咽癌患者,UNI可作为豁免未受累下颈照射的可选方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This meta-analysis aimed to investigate the efficacy and radiation-related toxicities of upper-neck irradiation (UNI) over whole-neck irradiation (WNI) in patients with unilateral or bilateral node-negative nasopharyngeal carcinoma. METHODS: We conducted a systematic review to identify studies comparing survival and toxicities between UNI and WNI by searching key databases up to Aug 2022. Hazard ratios (HRs) with 95% confidence intervals (CIs) for regional recurrence-free survival (RRFS), local recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) were pooled using R 4.0.5. Risk ratios (RRs) for acute and late radiation-related toxicities were also pooled. Subgroup analyses according to nodal status, radiotherapy techniques, and study type were conducted. RESULTS: Eight studies enrolling 2568 patients were included. Patients who received UNI showed similar RRFS (HR 0.99, 95% CI 0.57-1.74, P = 0.975), LRFS (HR 0.86, 95% CI 0.53-1.41, P = 0.559), DMFS (HR 0.90, 95% CI 0.63-1.29, P = 0.581), PFS (1.10, 95% CI 0.73-1.67, P = 0.642), and OS (1.03, 95% CI 0.77-1.37, P = 0.866) compared with WNI. When stratified by nodal status, the pooled HRs for RRFS in patient subgroups with stage N0 disease, stage N1 with only retropharyngeal lymph nodes metastasis, and unilateral cervical lymph node metastasis were 0.46 (95% CI 0.04-5.16, P = 0.529), 1.12 (95% CI 0.29-4.38, P = 0.872), and 1.02 (95% CI 0.48-2.16, P = 0.968) respectively, none of which reached statistical significance. UNI was associated with lower incidences of grade 1-2 hypothyroidism (RR 0.75, 95% CI 0.57-0.97, P = 0.031) and grade 1-2 dysphagia (RR 0.58, 95% CI 0.42-0.80, P < 0.001) compared with WNI. CONCLUSION: UNI had similar efficacy and fewer toxicities compared with WNI for patients with unilateral or bilateral node-negative nasopharyngeal carcinoma. The lower-neck sparing of the uninvolved neck is a valid option for N0, N1, and even unilateral N3 diseases in nasopharyngeal carcinoma.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Ding X, Cui X, Cui X, et al. Efficacy and toxicities of elective upper-neck irradiation versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: A meta-analysis. Radiother Oncol. 2023. PMID: 37625701. doi:10.1016/j.radonc.2023.109860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。